Page last updated: 2024-09-03
morphiceptin and Irritable Bowel Syndrome
morphiceptin has been researched along with Irritable Bowel Syndrome in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, C; Cygankiewicz, AI; Fichna, J; Krajewska, WM; Małecka-Panas, E; Mokrowiecka, A; Sałaga, M; Wlaź, P; Zakrzewski, PK; Zielińska, M | 1 |
Other Studies
1 other study(ies) available for morphiceptin and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome.
Topics: Abdominal Pain; Administration, Oral; Adult; Aged; Analgesics; Animals; Antidiarrheals; Case-Control Studies; Colon; Diarrhea; Disease Models, Animal; Endorphins; Gastrointestinal Transit; Humans; Ileum; Irritable Bowel Syndrome; Male; Mice, Inbred BALB C; Middle Aged; Muscle Contraction; Muscle, Smooth; Mustard Plant; Plant Oils; Receptors, Opioid; Young Adult | 2015 |